CN100444835C - Tendon-relaxing blood circulation-activating capsule and preparation process thereof - Google Patents

Tendon-relaxing blood circulation-activating capsule and preparation process thereof Download PDF

Info

Publication number
CN100444835C
CN100444835C CNB2006100317341A CN200610031734A CN100444835C CN 100444835 C CN100444835 C CN 100444835C CN B2006100317341 A CNB2006100317341 A CN B2006100317341A CN 200610031734 A CN200610031734 A CN 200610031734A CN 100444835 C CN100444835 C CN 100444835C
Authority
CN
China
Prior art keywords
blood circulation
tendon
preparation technology
hours
decocted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB2006100317341A
Other languages
Chinese (zh)
Other versions
CN1883635A (en
Inventor
翁小涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan 100041 cottage pharmaceutical Limited by Share Ltd
Original Assignee
CHANGSHA BAOJIAN BIOENGINEERING Co Ltd HUNAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGSHA BAOJIAN BIOENGINEERING Co Ltd HUNAN filed Critical CHANGSHA BAOJIAN BIOENGINEERING Co Ltd HUNAN
Priority to CNB2006100317341A priority Critical patent/CN100444835C/en
Publication of CN1883635A publication Critical patent/CN1883635A/en
Application granted granted Critical
Publication of CN100444835C publication Critical patent/CN100444835C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a capsule for relaxing tendons and activating blood circulation and a preparation technology of the capsule. Safflower, nutgrass galingale rhizome, east asian tree fern, Chinese silkvine bark are pulverized into fine powder and are sieved; native copper is added with 8 times amount of water to be decocted for two hours; then, Chinese starjasmine, common clubmoss herb, herba lycopi, coloed mistletoe herb and suberect spatholobus stem are decocted by twice; at the first time, 12 times amount of water is added to be decocted for three hours; at the second time, 10 times amount of water is added to be decocted for two hours; the decocted liquid is merged, filtered and statically placed; supernatant fluid is decompressed and concentrated into thick paste; 256g of powder and 28 to 30g of starch are added to be manufactured into 1000 granules through uniform mixing, granulating, drying and granule trimming. The product prepared with preparation technology of the present invention has stable and reliable product quality and moisture prevention and good economic benefits, masks the bitterness of original drugs and shortens disintegration time limited; the product is suitable for patients who do not eat sugar and provides good medication selection for both doctors and patients. The preparation technology of the present invention has the advantages of energy saving, reduction of production period and cost, integrity, perfection and large-scale industrialization.

Description

Tendon-relaxing blood circulation-activating capsule and preparation technology thereof
Technical field
The present invention relates to a kind of Chinese patent medicine tendon-relaxing blood circulation-activating capsule and preparation technology thereof.
Background technology
In the existing Chinese medicine preparation, tablet for relieving rigidity of muscles and promoting blood circulation has relaxing muscles and tendons and activating QI and blood in the collateral, the effect of promoting blood circulation to remove blood stasis.Be used for the treatment of bones and muscles pain, limbs are arrested twin, aching pain in waist and back, slight illness such as traumatic injury.But existing tablet for relieving rigidity of muscles and promoting blood circulation is plain sheet, and disintegration is long, and the effective ingredient dissolution rate in the tablet is slow, bitter in the mouth.And contain happy sugar in the tablet for relieving rigidity of muscles and promoting blood circulation, be unfavorable for that then some sugar avoiding patients take.Original in addition tablet for relieving rigidity of muscles and promoting blood circulation preparation technology is perfect inadequately, and some influence the not explanation of factors of effective component extracting effect, as amount of water what, concentrates, exsiccant condition etc.If will make tendon-relaxing blood circulation-activating capsule into, then should adopt which kind of adjuvant just suitable, how many consumptions is, how could more favourable sugar avoiding patients take; The technology of what kind of production is only the optimal preparation technology of tendon-relaxing blood circulation-activating capsule, how to reduce cost as much as possible, improves the quality, and helps the problem that large-scale industrial production all is the required solutions of the present inventor.
Summary of the invention
Purpose of the present invention aims to provide a kind of stripping that can favourable effective ingredient, more stable quality is reliable, has protection against the tide, and can cover former medicine bitterness, shortens disintegration, and can produce the tendon-relaxing blood circulation-activating capsule of better economic benefit.
Another object of the present invention be intended to a kind of can be energy-conservation well, shorten the production cycle, reduce production costs, technology is more complete, and is perfect, the preparation technology of the tendon-relaxing blood circulation-activating capsule of favourable large-scale industrial production.
The objective of the invention is to realize by following manner:
Capsule of the present invention is formed by following feedstock production, Flos Carthami 21g, Rhizoma Cyperi (system) 78.6g, Rhizoma Cibotii (system) 104.8g, Cortex Periplocae 52.4g, Caulis Trachelospermi 78.6g, Herba Lycopodii 78.6g, herba lycopi 78.6g, Herba Visci 104.8g, Caulis Spatholobi 78.6g, Pyritum (forging) 13.1g; Add supplementary product starch 28-30g.
Preparation technology of the present invention is: above ten flavors, earlier Flos Carthami, Rhizoma Cyperi, Rhizoma Cibotii, Cortex Periplocae are ground into fine powder, and sieve; Pyritum adds 8 times of water gagings and decocted 2 hours, adds Caulis Trachelospermi, Herba Lycopodii, herba lycopi, Herba Visci, Caulis Spatholobi decoction secondary then, adds 12 times of water gagings 3 hours for the first time, adds 10 times of water gagings 2 hours for the second time, collecting decoction filters, and leaves standstill, supernatant adopts the concentrating under reduced pressure method, and temperature is controlled at 60-70 ℃, and vacuum is that 0.07-0.08Mpa is condensed into thick paste, add above-mentioned powder 256g, add starch 28-30g, mixing, granulate drying, granulate, encapsulated, make 1000, promptly.
Described granulation is to granulate through 20 mesh sieves.
Exsiccant temperature is controlled at 70 ℃, and temperature rises gradually when dry, so that intragranular water evaporates.The granule water content is controlled at less than 2%.
Described granulate is through using 20 mesh sieve granulate.
Production technology of the present invention is that the present inventor fully studies and test of many times obtains, and below is the inventor's development test situation.
The investigation of water extraction condition
Get Pyritum 2.5g (adding 8 times of water gagings earlier decocted 2 hours), Caulis Trachelospermi 15g, Herba Lycopodii 15g, herba lycopi 15g, Herba Visci 20g, Caulis Spatholobi 15g (82.5g altogether), doubly amount, soak time, extraction time are the examination factor to add water, each factor is selected three different levels, and the factor level table sees Table 1.Promoting yield of extract with water serves as to investigate index, determines optimised process, presses L 9(3 4) table does orthogonal test.
Table 1 factor level table
Figure C20061003173400041
(1) water is promoted extractum preparation and yield determination method
Get Pyritum 2.5g (adding 8 times of water gagings earlier decocted 2 hours), Caulis Trachelospermi 15g, Herba Lycopodii 15g, herba lycopi 15g, Herba Visci 20g, Caulis Spatholobi 15g (82.5g altogether) in the prescription ratio, decoct with water by Orthogonal Experiment and Design and (to weigh earlier before each the extraction, boil to preceding 10 minutes of stipulated time and weigh and add water again to former weight, boiled again 10 minutes), filter, filtrate is concentrated into small size, move in the evaporating dish of known weight, put evaporate to dryness in the water-bath, again in 105 ℃ of dryings 3 hours, put in the exsiccator and cooled off 0.5 hour, precision is weighed, and is calculated as follows dried cream yield.
(2) water is proposed orthogonal test scheme, result and variance analysis
Table 2 water is carried orthogonal test scheme and table as a result
Table 3 water is carried the dried cream yield of quadrature analysis of variance table
Figure C20061003173400052
Wherein " * " looks into F-distribution critical table: F for significant difference is arranged 0.05(2,2)=and 19.00. promotes cream yield The results of analysis of variance as can be known from table 4 water: the C factor has significant difference (P<0.05), A, B factor there was no significant difference (P>0.05), that is: there is appreciable impact extraction time to dried cream yield, and amount of water, soak time do not make significant difference.By range analysis as can be known, the influence to dried cream yield is in proper order: C>A>B, A in the A factor 3>A 2>A 1, select best level A 3, B in the B factor 1>B 2>B 3, select best level B 1, C in the C factor 3>C 2>C 1, select best level C 3, the intuitive analysis result shows that optimised process consists of A 3B 1C 3The material of promptly getting it filled decocts with water secondary, adds 12 times of water gagings 3 hours for the first time, adds 10 times of water gagings 2 hours for the second time.
The condition of concentrating
Concentrate with two kinds of methods of concentrating under reduced pressure through normal pressure and to compare: adopt the concentrating under reduced pressure method, temperature is controlled at 60-70 ℃, and vacuum is 0.07-0.08Mpa, can shorten concentration time, reduces the ointment loss, preserves the effective ingredient in the medicinal liquid.
Study on Forming
The selection of adjuvant
Replace adjuvant with medical material fine powders such as Flos Carthamis in the moulding process, whole compositions of medicine both can have been preserved, escapable cost again, so in the moulding process of capsule still with medical material fine powder instead of part adjuvants such as Flos Carthamis, the inventor considers the demand of some sugar avoiding patient, do not re-use maltose, only add starch and supply weight.
Get medical material fine powder such as thick paste of the present invention and Flos Carthami and starch and mix, 20 mesh sieves are granulated.
Wet grain is dry: after wet granular of the present invention is made, and should be in time dry.Exsiccant temperature is controlled at 70 ℃, and temperature rises gradually when dry, so that intragranular water evaporates.The granule water content is controlled at less than 2%.
Granulate: during particle drying, in bulk is arranged slightly, through using 20 mesh sieve granulate, even particle size is convenient to fill.
Tablet for relieving rigidity of muscles and promoting blood circulation and tendon-relaxing blood circulation-activating capsule comparison sheet
Figure C20061003173400061
The above results shows: the former tablet for relieving rigidity of muscles and promoting blood circulation of the mass ratio of tendon-relaxing blood circulation-activating capsule of the present invention increases.
In sum, the stripping that product of the present invention can favourable effective ingredient, more stable quality is reliable, have protection against the tide, and can cover former medicine bitterness, shorten disintegration, help sugar avoiding patient and take, select, can produce better economic benefit for doctor and patient provides medication better.Preparation technology of the present invention can be energy-conservation well, shorten the production cycle, reduces production costs, and technology is more complete, and is perfect, favourable large-scale industrial production.
The specific embodiment
Flos Carthami 21g, Rhizoma Cyperi (system) 78.6g, Rhizoma Cibotii (system) 104.8g, Cortex Periplocae 52.4g, Caulis Trachelospermi 78.6g, Herba Lycopodii 78.6g, herba lycopi 78.6g, Herba Visci 104.8g, Caulis Spatholobi 78.6g, Pyritum (forging) 13.1g;
Preparation technology of the present invention is: above ten flavors, earlier Flos Carthami, Rhizoma Cyperi, Rhizoma Cibotii, Cortex Periplocae are ground into fine powder, and sieve; Pyritum adds 8 times of water gagings and decocted 2 hours, add Caulis Trachelospermi, Herba Lycopodii, herba lycopi, Herba Visci, Caulis Spatholobi decoction secondary then, add for the first time 12 times of water gagings 3 hours, add for the second time 10 times of water gagings 2 hours, collecting decoction filters, and leaves standstill, supernatant adopts the concentrating under reduced pressure method, temperature is controlled at 60-70 ℃, and vacuum is that 0.07-0.08Mpa is condensed into thick paste, adds above-mentioned powder 256g, add starch 29g, mixing is granulated through 20 mesh sieves, and exsiccant temperature is controlled at 70 ℃, temperature rises gradually when dry, so that intragranular water evaporates.The granule water content is controlled at less than 2%.Through using 20 mesh sieve granulate, encapsulated, make 1000, promptly.

Claims (5)

1, tendon-relaxing blood circulation-activating capsule is formed by following feedstock production, Flos Carthami 21g, Rhizoma Cyperi 78.6g, Rhizoma Cibotii 104.8g, Cortex Periplocae 52.4g, Caulis Trachelospermi 78.6g, Herba Lycopodii 78.6g, herba lycopi 78.6g, Herba Visci 104.8g, Caulis Spatholobi 78.6g, Pyritum 13.1g; Add supplementary product starch 28-30g.
2, the preparation technology of the described tendon-relaxing blood circulation-activating capsule of claim 1 is: get Flos Carthami, Rhizoma Cyperi, Rhizoma Cibotii, Cortex Periplocae and be ground into fine powder, the average flour extraction of flos carthami is 96.98%, crosses 80 mesh sieves; The average flour extraction of Rhizoma Cyperi medical material is 97.28%, crosses 80 mesh sieves; The average flour extraction of Rhizoma Cibotii medical material is 97.24%; The average flour extraction of Cortex Periplocae medical material is 96.88%, Pyritum adds 8 times of water gagings and decocted 2 hours, adds Caulis Trachelospermi, Herba Lycopodii, herba lycopi, Herba Visci, Caulis Spatholobi decoction secondary then, adds 12 times of water gagings 3 hours for the first time, add for the second time 10 times of water gagings 2 hours, collecting decoction filters, and leaves standstill, supernatant adopts the concentrating under reduced pressure method, temperature is controlled at 60-70 ℃, and vacuum is that 0.07-0.08Mpa is condensed into thick paste, adds above-mentioned powder 256g, add starch 29g, mixing is granulated drying, granulate, encapsulated, make 1000, promptly.
3, the preparation technology of tendon-relaxing blood circulation-activating capsule according to claim 2, described granulation is to granulate through 20 mesh sieves.
4, the preparation technology of tendon-relaxing blood circulation-activating capsule according to claim 2, exsiccant temperature are controlled at 70 ℃, and the granule water content is controlled at less than 2%.
5, the preparation technology of tendon-relaxing blood circulation-activating capsule according to claim 2, described granulate is through using 20 mesh sieve granulate.
CNB2006100317341A 2006-05-30 2006-05-30 Tendon-relaxing blood circulation-activating capsule and preparation process thereof Active CN100444835C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100317341A CN100444835C (en) 2006-05-30 2006-05-30 Tendon-relaxing blood circulation-activating capsule and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100317341A CN100444835C (en) 2006-05-30 2006-05-30 Tendon-relaxing blood circulation-activating capsule and preparation process thereof

Publications (2)

Publication Number Publication Date
CN1883635A CN1883635A (en) 2006-12-27
CN100444835C true CN100444835C (en) 2008-12-24

Family

ID=37582018

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100317341A Active CN100444835C (en) 2006-05-30 2006-05-30 Tendon-relaxing blood circulation-activating capsule and preparation process thereof

Country Status (1)

Country Link
CN (1) CN100444835C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102198209B (en) * 2011-05-18 2012-12-05 杭州华东医药集团康润制药有限公司 Tendon-relaxing and blood-activating capsules and preparation process thereof
CN102652768A (en) * 2012-04-11 2012-09-05 南京同仁堂药业有限责任公司 Medicinal composition for relaxing tendons, activating collaterals, promoting blood circulation and removing blood stasis
CN114949096B (en) * 2022-07-08 2024-03-19 太极集团四川绵阳制药有限公司 Preparation method of tablet for relaxing muscles and stimulating blood circulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895549A (en) * 2006-06-13 2007-01-17 孙津舒 Soothe tendons and activating-blood anodyne plaster

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895549A (en) * 2006-06-13 2007-01-17 孙津舒 Soothe tendons and activating-blood anodyne plaster

Also Published As

Publication number Publication date
CN1883635A (en) 2006-12-27

Similar Documents

Publication Publication Date Title
CN101513437B (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN104771563B (en) The compound Chinese medicinal preparation and preparation method of a kind of kidney tonifying
CN102940695B (en) Medicine composition for treating gout
CN102475830B (en) Medicinal composition for treating coronary disease and angina pectoris, preparation method thereof and preparation thereof
CN100444835C (en) Tendon-relaxing blood circulation-activating capsule and preparation process thereof
CN102319357B (en) Lipid-lowering dispersible tablets and preparation technology thereof
CN108686113A (en) A kind of composition and preparation method thereof for alleviating three high diseases shape
CN109170476A (en) Health food containing witloof
CN102302609A (en) Compound traditional Chinese drug preparation for improving subhealth
CN101862442B (en) Cough-relieving Chinese medicinal composition and preparation method thereof
CN103055210A (en) Gout treating medicament (gout relieving capsules) and processing method thereof
CN101167951A (en) Traditional Chinese medicinal composition for treating diabetes and its preparation method
CN108619314A (en) A kind of preparation method of Chinese medicinal granule object
CN101491628B (en) Lycium-rehmannia preparation preparation method
CN102940747B (en) Medicine composition for treating gout
CN101461877B (en) Medicament composition for recovery of physical strength for women
CN101375962B (en) Formulation for activating blood and freeing collateral vessels and preparation method thereof
CN104784418A (en) Medicine for curing protrusion of lumbar intervertebral disc
CN100488495C (en) A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same
CN107789479A (en) A kind of Chinese medicine for being used to treat diabetes
CN101269180A (en) Traditional Chinese medicine compound preparation for treating nephritis and preparation method
CN1947779A (en) Traditional Chinese medicine granules for treating infantile cough and its prepn. method
CN101176776A (en) Medicament for curing flat wart
CN105477384A (en) Traditional Chinese medicine composition capable of reducing blood pressure and preparation method of composition
CN104740233A (en) Chinese medicinal composition and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HU'NAN TIANJI CAOTANG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: CHANGSHA BAOJIAN BIOENGINEERING CO., LTD., HUNAN

Effective date: 20120330

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 410008 CHANGSHA, HUNAN PROVINCE TO: 412100 ZHUZHOU, HUNAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20120330

Address after: 412100 Hunan County in Zhuzhou Province Lu Kou Zhen Wan Tang Cun (Lu Industrial Park)

Patentee after: Hunan Tianjicaotang Pharmaceutical Co., Ltd.

Address before: 410008 5 floor, new posts and Telecommunications Research Building, Dongfeng second village, Changsha City, Hunan Province

Patentee before: Changsha Baojian Bioengineering Co., Ltd., Hunan

EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20061227

Assignee: HUNAN DEKANG PHARMACEUTICAL CO., LTD.

Assignor: Changsha Baojian Bioengineering Co., Ltd., Hunan

Contract record no.: 2011430000163

Denomination of invention: Tendon-relaxing and blood-activating capsules and preparation process thereof

Granted publication date: 20081224

License type: Exclusive License

Record date: 20110905

LICC Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model
EC01 Cancellation of recordation of patent licensing contract

Assignee: HUNAN DEKANG PHARMACEUTICAL CO., LTD.

Assignor: Changsha Baojian Bioengineering Co., Ltd., Hunan

Contract record no.: 2011430000163

Date of cancellation: 20160831

LICC Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model
CP03 Change of name, title or address

Address after: 410000 No. 7, Huan Lian Road, Changsha hi tech Zone, Changsha, Hunan

Patentee after: Hunan 100041 cottage pharmaceutical Limited by Share Ltd

Address before: 412100 Yutang village, Lukou Town, Zhuzhou County, Hunan (Lukou Industrial Park)

Patentee before: Hunan Tianjicaotang Pharmaceutical Co., Ltd.

CP03 Change of name, title or address